Tailored Case Management for Diabetes and Hypertension
Launched by DUKE UNIVERSITY · Sep 16, 2009
Trial Information
Current as of June 10, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Enrolled and receiving primary care at one of 9 participating clinics in North Carolina
- • Diagnosis of diabetes as determined by billing data
- • Taking medication for diabetes
- • Diagnosis of hypertension as determined by billing data
- • Taking medication for hypertension
- • Most recent (within one year) Hemoglobin A1c \>= 7.5%
- Exclusion Criteria:
- • Active psychosis
- • Hospitalization for stroke, myocardial infarction (MI), or coronary artery revascularization in the past 6 months
- • Type I diabetes
- • Does not speak English
- • No access to a telephone
- • Institution-dwelling or receiving comprehensive professional home health care
- • Hearing or speech inadequate for long interactive phone conversations
- • Terminal illness or active treatment for cancer
- • Cognitive impairment too severe to understand instructions
About Duke University
Duke University, a leading academic and research institution located in Durham, North Carolina, is renowned for its commitment to advancing healthcare through innovative clinical research. With a strong emphasis on interdisciplinary collaboration, Duke conducts a wide array of clinical trials aimed at developing cutting-edge therapies and improving patient outcomes across various medical fields. The university's Clinical Research Institute provides comprehensive support for trial design, implementation, and regulatory compliance, ensuring that all research adheres to the highest ethical and scientific standards. Duke’s dedication to translating research findings into effective clinical practices underscores its role as a pivotal contributor to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Durham, North Carolina, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials